Navigation Links
Gene Studies of Male-Female Differences Often Flawed
Date:8/21/2007

Too often, statistics are weak or unsubstantiated, review finds

TUESDAY, Aug. 21 (HealthDay News) -- Claims of male-female differences in how genes affect disease often lack proper documentation or validation, experts report in the Aug. 22/29 issue of the Journal of the American Medical Association.

A team of researchers in Greece analyzed 77 studies that contained 432 gender-difference claims.

They found that 286 (66.2 percent) of these claims were decided in advance of the study, and 68 (15.7 percent) were drawn from post-study analyses. The analysis plan was unclear in 78 (18.1 percent) of the studies.

The review also found that appropriate documentation of gene-sex interaction was recorded in just 55 claims (12.7 percent), while there was insufficient documentation for 303 claims and invalid documentation for 74 claims.

Dr. Nikolaos A. Patsopoulos of the University of Ioannina School of Medicine and colleagues concluded that "the majority of these claims were insufficiently documented or spurious, and reporting of statistical interaction tests was rare."

"We hope that our empirical evaluation will help sensitize clinicians, geneticists, epidemiologists, and statisticians who are pursuing subgroup analyses by sex or other subgroups on genetic associations," the researchers said.

In many cases, the proof of any real gender-based gene differences was weak. For example, data for re-analysis of gender-difference claims were available for 188 comparisons, the research team said. Of those, 83 (44.1 percent) were nominally statistically significant, and more than half of those (44) failed to reach nominal statistical significance of a certain level, the review authors said.

Of 60 claims with seemingly "the best internal validity," only one was consistently replicated in at least two other studies.

Studies of gene-sex interactions shouldn't be abandoned but should be conducted using more rigorous standards and documentation, the Greek team said. In addition, the results of such studies should be replicated by several other studies before the findings are accepted as valid, they wrote.

More information

The U.S. Food and Drug Administration has more about gender and disease.



-- Robert Preidt



SOURCE: JAMA news release, Aug. 21, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Studies On Hearing Loss Discovers New Causes
2. Broccoli Found to Block Cancer Progression In Both Animal and Human Studies
3. Studies Report Mammograms Unsafe
4. Six Indians Win Australian Studies Fellowships
5. Cure For Autism Could Be Established Through Hamster Studies
6. Despite More Studies Researchers Are Still Confound With ADHD
7. Studies Show Brain becomes Less Specialized With Age
8. ISB To Establish Research Chair On Real Estate And Urban Studies
9. Studies Show Combination Drugs As A Poor Substitute For Anti-Coagulants In Stroke
10. Further Studies Needed To Completely Understand About Ventricular Fibrillation
11. Circumcision Studies to Continue Says Health Panel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , ... March 29, 2017 , ... ... several educational opportunities for attending prescribers at the upcoming World Congress, in Hollywood ... “A4M has always been recognized as the visionary leader in the training of ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... Hours at a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest ... in two southeastern states. Ingredients in HeartBoost, an over the counter heart healthy ...
(Date:3/29/2017)... ... March 29, 2017 , ... The ... a referral to new patients from Burnaby, BC. Patients in need of experienced ... reconstruction services, can see the esteemed team at Wall Centre Dental. Drs. Parviz ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... this webinar provides insight into the challenges employers face in trying to balance ... of managing employee benefits programs? Adding to the growing complexity, companies are ...
(Date:3/29/2017)... ... 29, 2017 , ... Patients interested in receiving quick and ... Jamie Cameron, with or without a referral. The FASTBRACES system is valued for ... each patient’s case, treatment with the FASTBRACES system could be completed in 120 ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... BOSTON , March 28, 2017 /PRNewswire/ ... today announced a partnership with premium news ... allows pharmaceutical companies to extract key insights from ... text mining technology. The Linguamatics I2E ... top 20 global pharmaceutical companies. The Linguamatics-Dow Jones ...
(Date:3/28/2017)... TEL AVIV, Israel , March 28, 2017 ... . This new business entity, Emosis Ltd, headquartered in ... and development of novel assays complementing the mother company existing technology ... support commercialization and sales development of Emosis kits. ... This strategic move starts building Emosis ...
(Date:3/28/2017)... Calif. , March 28, 2017  AcelRx ... focused on the development and commercialization of innovative ... announced that the European Medicines Agency (EMA) has ... tablet, 30 mcg) Marketing Authorisation Application (MAA) has ... the MAA is underway. The MAA for ARX-04 ...
Breaking Medicine Technology: